Vertigo, a symptom often encountered in clinical practice, presents unique diagnostic and therapeutic challenges. It is characterized by a sensation of motion where none exists or an exaggerated sense of motion in response to movement. This article aims to provide a comprehensive clinical approach to vertigo, facilitating accurate diagnosis and effective management.
Vertigo arises from a dysfunction in the vestibular system, which includes the inner ear and central brain structures. Imbalances in the processing of sensory information related to body position and movement can lead to vertigo. Conditions such as benign paroxysmal positional vertigo (BPPV), Meniere's disease, and vestibular neuritis are common causes.
Diagnosis involves a detailed patient history and physical examination, with emphasis on identifying specific triggers and the nature of the vertiginous episodes. The Dix-Hallpike maneuver and the head impulse test can help distinguish peripheral from central causes. Neuroimaging may be necessary when central causes are suspected.
Treatment of vertigo is primarily aimed at managing the underlying cause. For BPPV, canalith repositioning maneuvers are effective. Meniere's disease may require dietary modifications, diuretics, or even surgery. Vestibular rehabilitation therapy can be beneficial for persistent symptoms.
Recent advancements in the understanding of vertigo have led to the development of new diagnostic tools and treatment modalities. The use of vestibular suppressant medications is being reassessed, and novel therapeutic approaches such as gene therapy for inherited vestibular disorders are under investigation.
Vertigo presents a complex clinical picture requiring a meticulous approach for accurate diagnosis and management. By understanding its pathophysiology, recognizing its clinical presentations, and staying abreast of emerging trends, healthcare professionals can significantly improve patient outcomes.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation